Gilberto Castañeda Hernández

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Biopharmaceuticals have the potential to raise an immunogenic response in treated individuals, which may impact the efficacy and safety profile of these drugs. As a result, it is essential to evaluate immunogenicity throughout the different phases of the clinical development of a biopharmaceutical, including post-marketing surveillance. Although rigorous(More)
  • 1